Chimeric Therapeutics LimitedASX: CHM

A$30 million Equity Placement Agreement with L1 Capital

· Issued by Chimeric Therapeutics Limited

Filed with ASX · · 5 pages · English

• Initial Placement of A$500,000 in ordinary shares at A$0.10 each (being the closing bid price yesterday, 8 June 2022) and 15,000,000 unlisted options exercisable at A$0.255 each expiring 31 March 2024 to be issued within seven days • Equity placement facility of up to a total of A$30 million over 24 months with L1 Capital, a leading global investment manager, by way of separate placements (the s

Chimeric Therapeutics Limited on 6ix

Earlier from Chimeric Therapeutics

Later from Chimeric Therapeutics

All Chimeric Therapeutics news releases